 |
 |
 |
|
Prevalence of rilpivirine resistance-associated mutations in US samples received for routine resistance testing
|
|
|
Reported by Jules Levin
XIX International AIDS Conference, Washington DC, USA, July 22-27 2012
Gaston R Picchio,1 Laurence T Rimsky,2 Veerle Van Eygen,2 Mojgan Haddad,3 Laura A Napolitano,3 Johan Vingerhoets2
1Janssen Research & Development LLC, Titusville, NJ, USA; 2Janssen Infectious Diseases BVBA, Beerse, Belgium; 3Monogram Biosciences, South San Francisco, CA, USA







|
|
|
 |
 |
|
|